NCT02582983View on ClinicalTrials.gov

A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) Infection

PHASE4CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
HIV Infections
Interventions
DRUG

Enfuvirtide

All participants received enfuvirtide 90 mg SC BID until 4 weeks after commercial availability was established in Thailand.

Trial Locations (5)

10110

Bangkok

10330

Bangkok

10700

Bangkok

11000

Nonthaburi

50200

Chiang Mai

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02582983 - A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) Infection | Biotech Hunter | Biotech Hunter